The content is available as a PDF (576.5 KB).
editorial . 2020 Aug 18:ciaa1211. doi: 10.1093/cid/ciaa1211
The challenge of managing COVID-19 associated pulmonary aspergillosis
Roger J Brüggemann
1,2,✉, Frank L van de Veerdonk
2,3, Paul E Verweij
2,4
Roger J Brüggemann, PharmD, PhD
1
Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands
2
Center of Expertise in Mycology Radboudumc/ CWZ and Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
Find articles by Roger J Brüggemann
Frank L van de Veerdonk, MD, PhD
2
Center of Expertise in Mycology Radboudumc/ CWZ and Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
3
Department of Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands
Find articles by Frank L van de Veerdonk
Paul E Verweij, MD, PhD
2
Center of Expertise in Mycology Radboudumc/ CWZ and Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
4
Department of Medical Microbiology , Radboud university medical center, Nijmegen, The Netherlands
Find articles by Paul E Verweij
1
Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands
2
Center of Expertise in Mycology Radboudumc/ CWZ and Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
3
Department of Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands
4
Department of Medical Microbiology , Radboud university medical center, Nijmegen, The Netherlands
✉
Corresponding author: Roger J. Brüggemann, Department of Pharmacy, Radboud university medical center, Geert Grooteplein 10, 6525GA Nijmegen, The Netherlands, roger.bruggemann@radboudumc.nl
Received 2020 Jul 27.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7454346 PMID: 32810202
See commentary "Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study", ciaa1065.